Telomir Pharmaceuticals, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 05/09/2025 | 1.26 M | $4.06 M | -0.83% | 4.23% |
BLACKROCK, INC. | 05/02/2025 | 1.20 M | $3.88 M | 13.58% | 4.03% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 429.25 K | $1.39 M | 3.77% | 1.44% |
NORTHERN TRUST CORP | 05/13/2025 | 154.07 K | $497.65 K | 1.61% | 0.52% |
STATE STREET CORP | 05/15/2025 | 125.67 K | $405.92 K | 8.53% | 0.42% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 91.35 K | $295.07 K | 26.36% | 0.31% |
SUNCOAST EQUITY MANAGEMENT | 04/22/2025 | 51.19 K | $165.36 K | 0.00% | 0.17% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 46.41 K | $149.89 K | 0.00% | 0.16% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 43.00 K | $138.89 K | 100.00% | 0.14% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 32.28 K | $104.27 K | -36.11% | 0.11% |
MORGAN STANLEY | 05/15/2025 | 29.02 K | $93.74 K | -27.84% | 0.10% |
05/12/2025 | 24.99 K | $80.72 K | 100.00% | 0.08% | |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 23.70 K | $76.55 K | 100.00% | 0.08% |
BARCLAYS PLC | 05/15/2025 | 20.34 K | $66.00 K | -32.11% | 0.07% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 16.08 K | $51.94 K | 155.93% | 0.05% |
UBS GROUP AG | 05/13/2025 | 15.42 K | $49.79 K | -38.15% | 0.05% |
ATOM INVESTORS LP | 05/15/2025 | 14.66 K | $47.36 K | -2.36% | 0.05% |
CITIGROUP INC | 05/12/2025 | 13.89 K | $44.85 K | -8.87% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 12.33 K | $39.83 K | 100.00% | 0.04% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 11.80 K | $38.00 K | 0.00% | 0.04% |
RHUMBLINE ADVISERS | 05/29/2025 | 11.73 K | $37.89 K | 36.42% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 11.17 K | $36.07 K | 4.37% | 0.04% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 10.27 K | $33.18 K | 2.26% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 9.47 K | $30.60 K | -1.47% | 0.03% |
JPMORGAN CHASE & CO | 05/12/2025 | 9.28 K | $29.98 K | -77.61% | 0.03% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 9.06 K | $29.28 K | -38.39% | 0.03% |
05/09/2025 | 6.18 K | $19.95 K | 100.00% | 0.02% | |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.72 K | $8.78 K | 15.37% | 0.01% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 1.94 K | $6.27 K | 0.00% | 0.01% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 1.45 K | $4.70 K | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.26 K | $4.08 K | -71.32% | 0.00% |
FMR LLC | 05/12/2025 | 817 | $2.64 K | -41.35% | 0.00% |
CWM, LLC | 05/01/2025 | 669 | $2.00 K | 100.00% | 0.00% |
AMALGAMATED BANK | 04/25/2025 | 667 | $2.00 K | 301.81% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 531 | $1.00 K | -58.71% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 471 | $1.52 K | 0.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 438 | $1.73 K | 100.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 04/30/2025 | 183 | $591 | 38.64% | 0.00% |
STERLING CAPITAL MANAGEMENT LLC | 05/13/2025 | 148 | $478 | -44.98% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 104 | $336 | 100.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 05/13/2025 | 88 | $284 | 100.00% | 0.00% |
05/02/2025 | 3 | $10 | 0.00% | 0.00% | |
GOTHAM ASSET MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
05/05/2025 | 0 | $0 | -100.00% | 0.00% |
Telomir Pharmaceuticals, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Telomir Pharmaceuticals, Inc. Common Stock. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.26 M
BlackRock, Inc.: 1.2 M
GEODE CAPITAL MANAGEMENT, LLC: 429,252
NORTHERN TRUST CORP: 154,072
STATE STREET CORP: 125,673
Bank of New York Mellon Corp: 91,353
12.41% of Telomir Pharmaceuticals, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 3.77 M shares in the last 24 months. This purchase volume represents approximately $5.78 M in transactions.